GENTEX CORPORATION (GNTX) Spending and interest coverage
- R&D / revenue · 12 months: Value 7.87%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 1.55%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 7.87% | Research and development expense / revenue. Period ending 2026-06-30. $206.78M ÷ $2.63B × 100 ≈ 7.87% |
| Stock-based compensation / revenue · 12 months | 1.55% | Share-based compensation / revenue. Period ending 2026-06-30. $40.63M ÷ $2.63B × 100 ≈ 1.55% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 206.78M USD | Research and Development Expense |
| Revenue | 2.63B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 40.63M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 507.43M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $206.78M | $2.63B | $40.63M | $507.43M | (m) | 7.87% | 1.55% | (m) | (m) |
| 2026-03-31 | $208.99M | $2.63B | $38.39M | $484.61M | (m) | 7.94% | 1.46% | (m) | (m) |
| 2025-12-31 | $203.26M | $2.53B | $36.65M | $473.94M | (m) | 8.02% | 1.45% | (m) | (m) |
| 2025-09-30 | $197.09M | $2.43B | $35.20M | $443.60M | (m) | 8.11% | 1.45% | (m) | (m) |
| 2025-06-30 | $192.68M | $2.38B | $34.30M | $447.00M | (m) | 8.08% | 1.44% | (m) | (m) |
| 2025-03-31 | $185.22M | $2.30B | $37.74M | $443.37M | (m) | 8.05% | 1.64% | (m) | (m) |
| 2024-12-31 | $181.48M | $2.31B | $39.54M | $459.73M | (m) | 7.84% | 1.71% | (m) | (m) |
| 2024-09-30 | $175.95M | $2.36B | $40.92M | $502.73M | (m) | 7.45% | 1.73% | (m) | (m) |
| 2024-06-30 | $167.92M | $2.33B | $42.33M | $499.42M | (m) | 7.21% | 1.82% | (m) | (m) |
| 2024-03-31 | $161.89M | $2.34B | $41.15M | $511.83M | (m) | 6.92% | 1.76% | (m) | (m) |
| 2023-12-31 | $154.36M | $2.30B | $39.20M | $495.73M | (m) | 6.71% | 1.70% | (m) | (m) |
| 2023-09-30 | $147.76M | $2.20B | $36.47M | $457.07M | (m) | 6.71% | 1.65% | (m) | (m) |
| 2023-06-30 | $141.10M | $2.12B | $33.13M | $421.45M | (m) | 6.65% | 1.56% | (m) | (m) |
| 2023-03-31 | $135.99M | $2.00B | $31.96M | $379.95M | (m) | 6.79% | 1.60% | (m) | (m) |
| 2022-12-31 | $133.31M | $1.92B | $30.23M | $370.01M | (m) | 6.95% | 1.58% | (m) | (m) |
| 2022-09-30 | $129.68M | $1.85B | $30.28M | $363.85M | (m) | 7.03% | 1.64% | (m) | (m) |
| 2022-06-30 | $125.88M | $1.75B | $30.16M | $365.22M | (m) | 7.19% | 1.72% | (m) | (m) |
| 2022-03-31 | $122.09M | $1.72B | $28.32M | $379.35M | (m) | 7.12% | 1.65% | (m) | (m) |
| 2021-12-31 | $117.76M | $1.73B | $27.42M | $409.78M | (m) | 6.80% | 1.58% | (m) | (m) |
| 2021-09-30 | $115.98M | $1.84B | $27.65M | $484.24M | (m) | 6.30% | 1.50% | (m) | (m) |
| 2021-06-30 | $114.04M | $1.92B | $27.46M | $534.93M | (m) | 5.95% | 1.43% | (m) | (m) |
| 2021-03-31 | $113.97M | $1.72B | $30.34M | $428.26M | (m) | 6.63% | 1.77% | (m) | (m) |
| 2020-12-31 | $115.94M | $1.69B | $30.80M | $399.56M | (m) | 6.87% | 1.82% | (m) | (m) |
| 2020-09-30 | $115.26M | (m) | $29.01M | $348.04M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $116.85M | (m) | $27.49M | $337.33M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $116.21M | (m) | $23.16M | $471.97M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $114.69M | $1.86B | $21.67M | $488.54M | (m) | 6.17% | 1.17% | (m) | (m) |
| 2019-09-30 | $112.84M | (m) | $20.67M | $503.14M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $110.33M | (m) | $19.79M | $502.43M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $109.17M | (m) | $19.19M | $501.21M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $107.13M | (m) | $18.31M | $508.13M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $104.70M | (m) | $18.84M | $516.62M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $102.58M | (m) | $17.92M | $518.27M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $100.62M | (m) | $17.93M | $517.45M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $99.73M | (m) | $18.38M | $523.36M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $99.66M | (m) | $17.78M | $517.30M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $98.47M | (m) | $18.53M | $522.44M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $96.30M | (m) | $18.64M | $525.32M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $94.24M | (m) | $19.19M | $511.74M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $92.73M | (m) | $19.40M | $510.47M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $90.65M | (m) | $19.98M | $492.52M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $89.90M | (m) | $20.59M | $471.91M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $88.39M | (m) | $21.43M | $458.77M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $87.19M | (m) | $22.24M | $430.72M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $87.36M | (m) | $22.35M | $417.66M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $85.27M | (m) | $22.35M | $409.37M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $84.18M | (m) | $21.28M | $398.83M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $82.24M | (m) | $20.47M | $395.85M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $79.67M | (m) | $19.50M | $366.30M | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $78.30M | (m) | $18.32M | $338.07M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $76.50M | (m) | $17.43M | $304.74M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $75.22M | (m) | $16.60M | $262.92M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $76.54M | (m) | $16.52M | $246.89M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $80.47M | (m) | $16.32M | $232.81M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $85.00M | (m) | $16.43M | $234.46M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $88.25M | (m) | $16.37M | $236.42M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $88.48M | (m) | $15.77M | $241.04M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $85.93M | (m) | $15.06M | $236.78M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $81.63M | (m) | $14.20M | $231.37M | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | $77.90M | (m) | $13.17M | $226.19M | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $73.70M | (m) | $12.20M | $210.92M | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | $68.68M | (m) | $11.42M | $206.46M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $64.10M | (m) | $10.65M | $190.97M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $47.13M | (m) | $9.08M | $94.62M | (m) | (m) | (m) | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $51.89M | (m) | $10.22M | $108.81M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Garrett Motion Inc. (GTX) | $4.732B | 9.95 | |
| Atmus Filtration Technologies Inc. (ATMU) | United States | $3.656B | 19.39 |
| Dorman Products, Inc. (DORM) | United States | $3.641B | 18.26 |
| LEAR CORP (LEA) | United States | $5.831B | 11.79 |
| Versigent PLC (VGNT) | $3.205B | ||
| DANA Inc (DAN) | United States | $2.944B | 2.63 |
| VISTEON CORP (VC) | United States | $2.398B | 16.55 |
| PHINIA INC. (PHIN) | United States | $2.197B | 22.60 |
| PATRICK INDUSTRIES INC (PATK) | United States | $2.176B | 20.75 |
| LCI INDUSTRIES (LCII) | United States | $2.034B | 12.21 |